Background: Cow's milk allergy (CMA) is a common disease of infancy and chi
ldhood. An appropriate cow's milk (CM) substitute is necessary for feeding
babies with CMA. CM substitutes are soy formulas and casein- or whey-based
extensively hydrolyzed formulas. In several countries, including Italy, goa
t's milk (GM) formulas are available, and some physicians recommend them fo
r feeding babies with CMA.
Objective: We sought to investigate, in vitro and in vivo, the allergenicit
y of GM in 26 children with proven IgE-mediated CMA.
Methods: All the children underwent skin tests with CM and GM; detection of
specific serum IgE to CM and GM; and double-blind, placebo-controlled, ora
l food challenges (DBP-COFCs) with fresh CM, GM, and, as placebo, a soy for
mula (Isomil, Abbott, Italy), CAP inhibition and immunoblotting inhibition
assays were also carried out in 1 of 26 and 4 of 26 children with positive
RAST results to both CM and GM, respectively.
Results: All the children had positive skin test responses and CAP results
to both CM and GM, all had positive DBPCOFC results to CM, and 24 of 26 had
positive DBPCOFCs to GM. In CAP inhibition tests, preincubation of serum w
ith CM or GM strongly inhibited IgE either to CM or to GM, In immunoblottin
g inhibition assays, preincubation with CM completely extinguished reactivi
ty to GM, whereas GM partially inhibited reactivity to CM.
Conclusions: These data strongly indicate that GM is not an appropriate CM
substitute for children with IgE-mediated CMA. A warning on the lack of saf
ety of GM for children with CMA should be on the label of GM formulas to pr
event severe allergic reactions in babies with CMA.